Acute stress in adolescence vs early adulthood following selective deletion of dysbindin-1A: Effects on anxiety, cognition and other schizophrenia-related phenotypes.


Journal

Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 27 9 2019
medline: 15 8 2020
entrez: 27 9 2019
Statut: ppublish

Résumé

As exposure to stress has been linked to the onset and maintenance of psychotic illness, its pathogenesis may involve environmental stressors interacting with genetic vulnerability. To establish whether acute stress interacts with a targeted mutation of the gene encoding the neurodevelopmental factor dystrobrevin-binding protein 1 (DTNBP1), resulting in a specific loss of the isoform dysbindin-1A, to influence schizophrenia-relevant phenotypes in mice during adolescence and adulthood. Male and female mice with a heterozygous or homozygous deletion of DTNBP1 were assessed in the open field test following acute restraint stress in adolescence (Day 35) and young adulthood (Day 60-70). Effects of acute restraint stress on memory retention in the novel object recognition test was also assessed in adulthood. Baseline corticosterone was measured in serum samples and, brain-derived neurotrophic factor (BDNF), glucocorticoid and mineralocorticoid receptor gene expression levels were measured in the hippocampus of adult mice. In the open field, deletion of dysbindin-1A induced hyperactivity and attenuated the action of stress to reduce hyperactivity in adolescence but not in adulthood; in females deletion of dysbindin-1A attenuated the effect of acute stress to increase anxiety-related behaviour in adolescence but not in adulthood. In the novel object recognition test, deletion of dysbindin-1A impaired memory and also revealed an increase in anxiety-related behaviour and a decrease in hippocampal BDNF gene expression in males. These data suggest that deletion of dysbindin-1A influences behaviours related to schizophrenia and anxiety more robustly in adolescence than in adulthood and that dysbindin-1A influences stress-related responses in a sex-dependent manner.

Sections du résumé

BACKGROUND
As exposure to stress has been linked to the onset and maintenance of psychotic illness, its pathogenesis may involve environmental stressors interacting with genetic vulnerability.
AIM
To establish whether acute stress interacts with a targeted mutation of the gene encoding the neurodevelopmental factor dystrobrevin-binding protein 1 (DTNBP1), resulting in a specific loss of the isoform dysbindin-1A, to influence schizophrenia-relevant phenotypes in mice during adolescence and adulthood.
METHODS
Male and female mice with a heterozygous or homozygous deletion of DTNBP1 were assessed in the open field test following acute restraint stress in adolescence (Day 35) and young adulthood (Day 60-70). Effects of acute restraint stress on memory retention in the novel object recognition test was also assessed in adulthood. Baseline corticosterone was measured in serum samples and, brain-derived neurotrophic factor (BDNF), glucocorticoid and mineralocorticoid receptor gene expression levels were measured in the hippocampus of adult mice.
RESULTS
In the open field, deletion of dysbindin-1A induced hyperactivity and attenuated the action of stress to reduce hyperactivity in adolescence but not in adulthood; in females deletion of dysbindin-1A attenuated the effect of acute stress to increase anxiety-related behaviour in adolescence but not in adulthood. In the novel object recognition test, deletion of dysbindin-1A impaired memory and also revealed an increase in anxiety-related behaviour and a decrease in hippocampal BDNF gene expression in males.
CONCLUSIONS
These data suggest that deletion of dysbindin-1A influences behaviours related to schizophrenia and anxiety more robustly in adolescence than in adulthood and that dysbindin-1A influences stress-related responses in a sex-dependent manner.

Identifiants

pubmed: 31556815
doi: 10.1177/0269881119875465
doi:

Substances chimiques

Bdnf protein, mouse 0
Brain-Derived Neurotrophic Factor 0
Dtnbp1 protein, mouse 0
Dysbindin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1619

Auteurs

Lieve Desbonnet (L)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
School of Psychology, National University of Ireland, Galway, Ireland.

Colm Mp O'Tuathaigh (CM)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
School of Medicine, Brookfield Health Sciences Complex, University College Cork, Cork, Ireland.

Clare O'Leary (C)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Rachel Cox (R)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.

Orna Tighe (O)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.

Emilie I Petit (EI)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.

Steve Wilson (S)

In Vivo Science and Delivery, GlaxoSmithKline, Stevenage, UK.

John L Waddington (JL)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psychiatric Disorders and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH